查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446409

白蛋白市場：按類型、應用、銷售管道分類：2023-2032 年全球機會分析與產業預測

Albumin Market By Type, By Application, By Sales Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 287 Pages | 商品交期: 2-3個工作天內

價格
白蛋白市場-IMG1

此外，白蛋白市場的成長是由主要產業參與者不斷實施關鍵策略（如產品發布、收購和協議）所推動的。

例如，2020年9月，生命科學研究和生物製藥行業領先的國際合作夥伴賽多利斯集團宣布收購基於重組白蛋白的解決方案領域的領導者Albumedix Ltd。此外，全球大型公司的血漿源藥物製造商 Grifols 宣布推出其白蛋白產品組合的最新創新產品 ALBUTEIN FlexBag，濃度為 5% 和 25%。此類策略措施不僅推動創新，還透過滿足醫療保健和生物製藥行業不斷變化的需求來加速市場成長。

此外，技術進步也是白蛋白市場成長的主要促進因素。在製藥和生物技術領域，生產製程和精製技術的不斷創新正在提高白蛋白產品的效率和品質。先進技術也有助於開發新型白蛋白製劑，擴大其在藥物傳遞系統和診斷的應用。製造、精製和分析的高精度確保了雜質最少的高品質白蛋白，並滿足嚴格的監管標準。此外，技術進步將有助於探索白蛋白生產的替代來源並解決供應鏈挑戰。技術與白蛋白生產之間的協同效應不僅改進了現有產品，而且促進了尖端解決方案的創建，並推動了白蛋白市場的整體擴張。

白蛋白市場按類型、應用、銷售管道和地區細分。依類型分為人類血清白蛋白、牛血清白蛋白、重組白蛋白。依用途分為治療藥物、製劑/疫苗、培養基成分等。依銷售管道分類，銷售分為企業對企業（B2B）及消費者對消費者（B2C）。按地區分類，我們有北美（美國、加拿大、墨西哥）、歐洲（德國、英國、英國、義大利、西班牙其他歐洲國家地區）、亞太地區（日本、中國、印度、澳洲、韓國、其他亞太地區），在亞太地區（巴西、中國、阿拉伯、亞太其他地區）進行分析。

相關人員的主要利益

  • 本報告對 2022 年至 2032 年白蛋白市場分析的細分市場、當前趨勢、估計/趨勢分析和動態進行了定量分析，以確定白蛋白市場的有前景的機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析強調買家和供應商幫助相關人員做出利潤驅動的商業決策並加強供應商-買家網路的潛力。
  • 對白蛋白市場細分的詳細分析將有助於確定市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場公司定位有助於基準化分析並提供對市場公司當前地位的清晰了解。
  • 該報告包括對區域和全球白蛋白市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

可以使用此報告進行報告客製化（可能需要額外費用和時間表）

  • 國家、區域和全球各級的患者/流行病學資料
  • 監管指引
  • 針對客戶興趣的其他公司簡介
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 贖回場景
  • SWOT分析

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 手術數量增加
      • 提高捐血意識
      • 在藥物開發中增加血漿來源白蛋白的使用
    • 抑制因素
      • 嚴格的政府法規
    • 機會
      • 新興市場的成長機會

第4章白蛋白市場：依類型

  • 概述
  • 人血清白蛋白
  • 牛血清白蛋白
  • 基因改造白蛋白

第5章白蛋白市場：依應用分類

  • 概述
  • 治療藥物
  • 藥物製劑和疫苗
  • 中等成分
  • 其他

第6章白蛋白市場：依銷售管道分類

  • 概述
  • B2C
  • B2B
    • B2B 白蛋白市場：依類型
      • 藥用白蛋白市場：依類型
      • 非醫用白蛋白市場：依類型

第7章按地區分類的白蛋白市場

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • Merck KGaA
  • Sartorius AG
  • Octapharma AG
  • Thermo Fisher Scientific Inc.
  • Ventria Bioscience Inc.
  • Grifols, SA
  • CSL
  • China Biologic Products Holdings, Inc
  • Lazuline Bio
  • Takeda Pharmaceutical Company Limited
Product Code: A02251
Albumin Market - IMG1

Furthermore, the growth of the albumin market is propelled by the increasing implementation of key strategies among major industry players, including product launches, acquisitions, and agreements. For instance, in September 2020, Sartorius Group, a leading international partner of life science research and the biopharmaceutical industry, announced acquisition of Albumedix Ltd, a leader in the field of recombinant albumin-based solutions. In addition, Grifols, a leading global producer of plasma-derived medicines, announced the launch of its latest albumin portfolio innovation, ALBUTEIN FlexBag (Albumin [Human] U.S.P.) in 5% and 25% concentrations. These strategic moves not only drive innovation but also foster market growth by catering to the evolving needs of the healthcare and biopharmaceutical industries.

In addition, technological advancements are key drivers of the growing albumin market. In the pharmaceutical and biotechnology sectors, continuous innovations in production processes and purification techniques enhance the efficiency and quality of albumin products. Advanced technologies also contribute to the development of novel albumin-based formulations, expanding their applications in drug delivery systems and diagnostics. Precision in manufacturing, purification, and analysis ensures high-quality albumin with minimal impurities, meeting stringent regulatory standards. In addition, technological progress facilitates the exploration of alternative sources for albumin production, addressing supply chain challenges. The synergy between technology and albumin production not only improves existing products but also fosters the creation of cutting-edge solutions, fueling the overall expansion of the albumin market.

The albumin market is segmented on the basis of type, application, sales channel, and region. On the basis of type, the market is categorized into human serum albumin, bovine serum albumin, and recombinant albumin. On the basis of application, it is classified into therapeutics, drug formulation & vaccines, component of media, and others. On the basis of sales channel, it is classified into business to business (B2B) and business to consumer (B2C). On the basis of region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major key players that operate in the global albumin market are Takeda Pharmaceutical Company Limited, Merck KGaA, Sartorius AG, Octapharma AG, Thermo Fisher Scientific Inc., Ventria Bioscience Inc, Grifols, S.A., CSL, China Biologic Products Holdings, Inc, and Lazuline Bio. The players have adopted investment, strategic alliance, product approval, clinical trials, expansion, agreement, and acquisition as the key strategies to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the albumin market analysis from 2022 to 2032 to identify the prevailing albumin market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the albumin market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global albumin market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario
  • SWOT Analysis

Key Market Segments

By Type

  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin

By Application

  • Therapeutics
  • Drug Formulation and Vaccines
  • Component of Media
  • Other

By Sales Channel

  • B2C
  • B2B
    • Type
    • Pharmaceutical Applications

Type

    • Non Pharmaceutical Applications

Type

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Octapharma AG
    • Grifols, S.A.
    • CSL
    • Ventria Bioscience Inc.
    • Lazuline Bio
    • Takeda Pharmaceutical Company Limited
    • Sartorius AG
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • China Biologic Products Holdings, Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in number of surgical procedures
      • 3.4.1.2. Growing awareness regarding blood donations.
      • 3.4.1.3. Rise in use of plasma derived albumin in drug development
    • 3.4.2. Restraints
      • 3.4.2.1. Stringent government regulations
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: ALBUMIN MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Human Serum Albumin
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Bovine Serum Albumin
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Recombinant Albumin
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: ALBUMIN MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Therapeutics
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Drug Formulation and Vaccines
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Component of Media
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Other
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: ALBUMIN MARKET, BY SALES CHANNEL

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. B2C
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. B2B
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
    • 6.3.4. B2B Albumin Market by Type
      • 6.3.4.1. Pharmaceutical Applications Albumin Market by Type
      • 6.3.4.2. Non Pharmaceutical Applications Albumin Market by Type

CHAPTER 7: ALBUMIN MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by Sales Channel
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Type
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by Sales Channel
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Type
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by Sales Channel
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Type
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by Sales Channel
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by Sales Channel
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Type
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by Sales Channel
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Type
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by Sales Channel
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Type
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by Sales Channel
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Type
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by Sales Channel
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Type
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by Sales Channel
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Type
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by Sales Channel
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by Sales Channel
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Type
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by Sales Channel
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Type
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by Sales Channel
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Type
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by Sales Channel
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Type
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by Sales Channel
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Type
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by Sales Channel
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Type
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by Sales Channel
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by Sales Channel
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Type
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by Sales Channel
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Type
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by Sales Channel
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Type
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by Sales Channel
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Type
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by Sales Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Merck KGaA
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Sartorius AG
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Octapharma AG
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Thermo Fisher Scientific Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Ventria Bioscience Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. Grifols, S.A.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. CSL
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. China Biologic Products Holdings, Inc
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Lazuline Bio
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. Takeda Pharmaceutical Company Limited
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 02. ALBUMIN MARKET FOR HUMAN SERUM ALBUMIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. ALBUMIN MARKET FOR BOVINE SERUM ALBUMIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. ALBUMIN MARKET FOR RECOMBINANT ALBUMIN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 06. ALBUMIN MARKET FOR THERAPEUTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. ALBUMIN MARKET FOR DRUG FORMULATION AND VACCINES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. ALBUMIN MARKET FOR COMPONENT OF MEDIA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. ALBUMIN MARKET FOR OTHER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 11. ALBUMIN MARKET FOR B2C, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. ALBUMIN MARKET FOR B2B, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL B2B ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL APPLICATIONS ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL NON PHARMACEUTICAL APPLICATIONS ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 16. ALBUMIN MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. U.S. ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. U.S. ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. U.S. ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 24. CANADA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. CANADA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. CANADA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 37. FRANCE ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. FRANCE ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. FRANCE ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 40. UK ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. UK ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. UK ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 43. ITALY ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. ITALY ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. ITALY ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 46. SPAIN ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. SPAIN ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. SPAIN ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 59. CHINA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. CHINA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. CHINA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 62. INDIA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. INDIA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. INDIA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 65. AUSTRALIA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. AUSTRALIA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. LAMEA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. LAMEA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 77. LAMEA ALBUMIN MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 78. BRAZIL ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 79. BRAZIL ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. BRAZIL ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 81. SAUDI ARABIA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 82. SAUDI ARABIA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. SAUDI ARABIA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 84. SOUTH AFRICA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 85. SOUTH AFRICA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH AFRICA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 87. REST OF LAMEA ALBUMIN MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 88. REST OF LAMEA ALBUMIN MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. REST OF LAMEA ALBUMIN MARKET, BY SALES CHANNEL, 2022-2032 ($MILLION)
  • TABLE 90. MERCK KGAA: KEY EXECUTIVES
  • TABLE 91. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 92. MERCK KGAA: PRODUCT SEGMENTS
  • TABLE 93. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 94. SARTORIUS AG: KEY EXECUTIVES
  • TABLE 95. SARTORIUS AG: COMPANY SNAPSHOT
  • TABLE 96. SARTORIUS AG: PRODUCT SEGMENTS
  • TABLE 97. SARTORIUS AG: PRODUCT PORTFOLIO
  • TABLE 98. SARTORIUS AG: KEY STRATERGIES
  • TABLE 99. OCTAPHARMA AG: KEY EXECUTIVES
  • TABLE 100. OCTAPHARMA AG: COMPANY SNAPSHOT
  • TABLE 101. OCTAPHARMA AG: PRODUCT SEGMENTS
  • TABLE 102. OCTAPHARMA AG: PRODUCT PORTFOLIO
  • TABLE 103. OCTAPHARMA AG: KEY STRATERGIES
  • TABLE 104. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 105. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 106. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 107. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 108. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 109. VENTRIA BIOSCIENCE INC.: KEY EXECUTIVES
  • TABLE 110. VENTRIA BIOSCIENCE INC.: COMPANY SNAPSHOT
  • TABLE 111. VENTRIA BIOSCIENCE INC.: PRODUCT SEGMENTS
  • TABLE 112. VENTRIA BIOSCIENCE INC.: PRODUCT PORTFOLIO
  • TABLE 113. GRIFOLS, S.A.: KEY EXECUTIVES
  • TABLE 114. GRIFOLS, S.A.: COMPANY SNAPSHOT
  • TABLE 115. GRIFOLS, S.A.: PRODUCT SEGMENTS
  • TABLE 116. GRIFOLS, S.A.: PRODUCT PORTFOLIO
  • TABLE 117. GRIFOLS, S.A.: KEY STRATERGIES
  • TABLE 118. CSL: KEY EXECUTIVES
  • TABLE 119. CSL: COMPANY SNAPSHOT
  • TABLE 120. CSL: PRODUCT SEGMENTS
  • TABLE 121. CSL: PRODUCT PORTFOLIO
  • TABLE 122. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: KEY EXECUTIVES
  • TABLE 123. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: COMPANY SNAPSHOT
  • TABLE 124. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: PRODUCT SEGMENTS
  • TABLE 125. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC: PRODUCT PORTFOLIO
  • TABLE 126. LAZULINE BIO: KEY EXECUTIVES
  • TABLE 127. LAZULINE BIO: COMPANY SNAPSHOT
  • TABLE 128. LAZULINE BIO: PRODUCT SEGMENTS
  • TABLE 129. LAZULINE BIO: PRODUCT PORTFOLIO
  • TABLE 130. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY EXECUTIVES
  • TABLE 131. TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT
  • TABLE 132. TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT SEGMENTS
  • TABLE 133. TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT PORTFOLIO
  • TABLE 134. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. ALBUMIN MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF ALBUMIN MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN ALBUMIN MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN ALBUMIN MARKET (2023-2032)
  • FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL ALBUMIN MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. ALBUMIN MARKET, BY TYPE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR HUMAN SERUM ALBUMIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR BOVINE SERUM ALBUMIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR RECOMBINANT ALBUMIN, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. ALBUMIN MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR THERAPEUTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR DRUG FORMULATION AND VACCINES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR COMPONENT OF MEDIA, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR OTHER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. ALBUMIN MARKET, BY SALES CHANNEL, 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR B2C, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ALBUMIN MARKET FOR B2B, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. ALBUMIN MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 24. U.S. ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. CANADA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. MEXICO ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. GERMANY ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. FRANCE ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. UK ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. ITALY ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. SPAIN ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. REST OF EUROPE ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. JAPAN ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. CHINA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. INDIA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. AUSTRALIA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SOUTH KOREA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. BRAZIL ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SAUDI ARABIA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. SOUTH AFRICA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF LAMEA ALBUMIN MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47. COMPETITIVE DASHBOARD
  • FIGURE 48. COMPETITIVE HEATMAP: ALBUMIN MARKET
  • FIGURE 49. TOP PLAYER POSITIONING, 2022
  • FIGURE 50. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. MERCK KGAA: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 53. SARTORIUS AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. SARTORIUS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. SARTORIUS AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. OCTAPHARMA AG: SALES REVENUE, 2020-2022 ($MILLION)
  • FIGURE 57. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. GRIFOLS, S.A.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. GRIFOLS, S.A.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. GRIFOLS, S.A.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 63. CSL: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 64. CSL: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 65. CSL: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 66. TAKEDA PHARMACEUTICAL COMPANY LIMITED: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 67. TAKEDA PHARMACEUTICAL COMPANY LIMITED: REVENUE SHARE BY REGION, 2023 (%)